Research ArticleCARDIOVASCULAR
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2-(1H)quinolinone (Cilostazol), a Phosphodiesterase Type 3 Inhibitor, Reduces Infarct Size via Activation of Mitochondrial Ca2+-Activated K+ Channels in Rabbit Hearts
Mika Fukasawa, Hirofumi Nishida, Toshiaki Sato, Masaru Miyazaki and Haruaki Nakaya
Journal of Pharmacology and Experimental Therapeutics July 2008, 326 (1) 100-104; DOI: https://doi.org/10.1124/jpet.108.136218
Mika Fukasawa
Hirofumi Nishida
Toshiaki Sato
Masaru Miyazaki
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCARDIOVASCULAR
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2-(1H)quinolinone (Cilostazol), a Phosphodiesterase Type 3 Inhibitor, Reduces Infarct Size via Activation of Mitochondrial Ca2+-Activated K+ Channels in Rabbit Hearts
Mika Fukasawa, Hirofumi Nishida, Toshiaki Sato, Masaru Miyazaki and Haruaki Nakaya
Journal of Pharmacology and Experimental Therapeutics July 1, 2008, 326 (1) 100-104; DOI: https://doi.org/10.1124/jpet.108.136218
Research ArticleCARDIOVASCULAR
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2-(1H)quinolinone (Cilostazol), a Phosphodiesterase Type 3 Inhibitor, Reduces Infarct Size via Activation of Mitochondrial Ca2+-Activated K+ Channels in Rabbit Hearts
Mika Fukasawa, Hirofumi Nishida, Toshiaki Sato, Masaru Miyazaki and Haruaki Nakaya
Journal of Pharmacology and Experimental Therapeutics July 1, 2008, 326 (1) 100-104; DOI: https://doi.org/10.1124/jpet.108.136218
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement